+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Drug Development"

From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
From
Advances in Cancer Research. Volume 152 - Product Thumbnail Image

Advances in Cancer Research. Volume 152

  • Book
  • August 2021
  • 312 Pages
DNA Repair in Cancer Therapy - Product Thumbnail Image

DNA Repair in Cancer Therapy

  • Book
  • November 2016
  • 330 Pages
Loading Indicator

The Cancer Drug Development market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs to treat cancer, a disease that affects millions of people worldwide. This market includes the research and development of new drugs, as well as the testing and approval of existing drugs for use in cancer treatment. Companies in this market must adhere to strict regulations and guidelines set by regulatory bodies such as the US Food and Drug Administration (FDA). The Cancer Drug Development market is highly competitive, with many companies vying for a share of the market. Companies in this market include large pharmaceutical companies, biotechnology companies, and smaller start-ups. Examples of companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more